SEC Form 4 · accession 0001209191-15-025188
Atara Biotherapeutics, Inc. · ATRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel S Marcus
Director
Period of report
Mar 9, 2015
Accepted (ET)
Mar 11, 2015 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2015 | P | 2,500 | $29.32 | A | 2,500 | I | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
| Common StockF2 | Mar 10, 2015 | P | 1,500 | $29.99 | A | 4,000 | I | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
| Common Stock | holding | — | — | — | 908,355 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased at prices ranging from $28.95 to $29.35. The reporting person will provide upon request to the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F2The shares were purchased at prices ranging from $29.97 to $30.00. The reporting person will provide upon request to the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.